Charles Sermon

Founder at MEREO BIOPHARMA GROUP PLC

Net worth: 75 357 $ as of 31/05/2026

56 year

29 connections

Commercial Services

Health Technology

Finance

Profile

Charles Edward Sermon is the founder of Mereo BioPharma Group Plc, founded in 2015, holding the title of Secretary, General Counsel & Business Development.
Current jobs include Director at Mereo BioPharma 3 Ltd., Director at Mereo BioPharma 2 Ltd. since 2015, Director at Mereo BioPharma 4 Ltd. since 2017, and Trustee at Rainbow Trust Children's Charity.
Former jobs include Partner at Phase4 Partners Ltd. from 2000 to 2022, Member-Digital, Creative & Science at London Enterprise Panel from 2013 to 2016, and a position at Freshfields in 2004.
Education includes graduation from The University of Hull.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
MEREO BIOPHARMA GROUP PLC 0.14%	26/03/2026	1,095,309 ( 0.14% )	75 357 $	31/05/2026

Charles Sermon active positions

Companies	Position	Start
MEREO BIOPHARMA GROUP PLC	Founder	01/03/2015
Mereo Biopharma 3 Ltd. Mereo Biopharma 3 Ltd. BiotechnologyHealth Technology Develops bio pharm products	Director/Board Member	-
Mereo BioPharma 2 Ltd. Mereo BioPharma 2 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and experimental development for biotechnology	Director/Board Member	30/06/2015
Mereo BioPharma 4 Ltd. Mereo BioPharma 4 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides biotechnological research and development services	Director/Board Member	24/10/2017
Rainbow Trust Children's Charity Rainbow Trust Children's Charity Miscellaneous Commercial ServicesCommercial Services Provides emotional and practical support services	Director/Board Member	-

All active positions of Charles Sermon

Former positions of Charles Sermon

Companies	Position	End
Phase4 Partners Ltd. Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It Participates in early and later stage capital requirements with an investment size of USD 15 - 30 million.	Investment Committee Member	28/02/2022
London Enterprise Panel	Corporate Officer/Principal	01/01/2016

See the detail of Charles Sermon's experience

Training of Charles Sermon

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Charles Sermon's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	8
Phase4 Partners Ltd. Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures invests in companies located in the United Kingdom. The firm focuses on a broad range of sectors and industries. It Participates in early and later stage capital requirements with an investment size of USD 15 - 30 million.	Finance
The University of Hull The University of Hull Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Rainbow Trust Children's Charity Rainbow Trust Children's Charity Miscellaneous Commercial ServicesCommercial Services Provides emotional and practical support services	Commercial Services
Mereo BioPharma Group Plc Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company	Health Technology
London Enterprise Panel
Mereo Biopharma 3 Ltd. Mereo Biopharma 3 Ltd. BiotechnologyHealth Technology Develops bio pharm products	Health Technology
Mereo BioPharma 2 Ltd. Mereo BioPharma 2 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and experimental development for biotechnology	Commercial Services
Mereo BioPharma 4 Ltd. Mereo BioPharma 4 Ltd. Miscellaneous Commercial ServicesCommercial Services Provides biotechnological research and development services	Commercial Services